In melanoma B16 cells and gastric cancer MKN-45 cells, shikonin promoted tumor cell apoptosis by inhibiting the phosphorylation of PKM2 and preventing the conformational transition of PKM2 tetramer to dimer, but did not reduce total levels of PKM2 (Zhao et al., 2018b). This evidence concerns the gene PKM and melanoma.